Evidence map›Paper›PMID 38601517›Full record

ArticleHeliyon2024

Yunhao Zhu, Xiangxiang Hu, Mengyi Qiao, Le Zhao, Chengming Dong

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yunhao ZhuSchool of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, Henan, PR China.
Xiangxiang HuSchool of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, Henan, PR China.
Mengyi QiaoSchool of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, Henan, PR China.
Le ZhaoSchool of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, Henan, PR China.
Chengming DongSchool of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, Henan, PR China.
First Affiliated Hospital of Henan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silver nanoparticles (AgNPs), widely recognized for their nanoscale geometric size and unique properties, such as large specific surface area, high permeability, and high safety, were synthesized using the endophytic fungus

Indexed as

Antimicrobial activityFungusGreen synthesisSeed germinationSilver nanoparticles

Identifiers

PMID38601517
PMCPMC11004220
OpenAlexW4393941712

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.